We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

ModiQuest Research Makes Antibody R&D Easier with their New Website

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

ModiQuest Research has announced the launch of their new website (www.modiquestresearch.com).

With a fresh new look, it will save time and effort for antibody research teams worldwide. An intuitive structure, ‘quick quotes’ and fixed pricing look set to make www.modiquestresearch.com the go-to resource for the routine purchase of a wide range of antibody products and services.

With customers from new start-ups to large, multi-national organizations, ModiQuest Research takes an intelligent approach to antibody design, modification, cloning and production.

The company is proud of its reputation for high-quality products. Proprietary tools and know-how that extends across the field of antibody research characterize the ModiQuest Research team.

Areas of activity include: monoclonal antibody generation, antibody cloning and sequencing, stable and transient cell line services, antibody production, and antibody modification services.

A young and dynamic company, ModiQuest Research focuses on high-throughput generation of monoclonal human- and animal-derived antibodies.

Antibodies are generated from both human and animal origin, using a large panel of technologies, such as ModiQuest Research’s proprietary hybridoma generation, B-cell selection and phage display.

Their growing range of immunological research products include specialist reagents for autoimmune diseases, infectious diseases and cancer.